Antimicrobial susceptibility profile of enteric bacterial isolates from tilapia and bangus sold in wet markets / by May M. Gatdula.
Material type: TextLanguage: English Publication details: Indang, Cavite : 2010. Cavite State University- Main Campus,Description: xiv, 74 pages : illustrations ; 28 cmContent type:- text
- unmediated
- volume
- 616.9041 G22 2010
- College of Arts and Science (CAS)
Item type | Current library | Collection | Call number | Materials specified | URL | Status | Notes | Date due | Barcode |
---|---|---|---|---|---|---|---|---|---|
Theses / Manuscripts | Ladislao N. Diwa Memorial Library Theses Section | Non-fiction | 616.9041 G22 2011 (Browse shelf(Opens below)) | Link to resource | Room use only | T-4283 | 00007952 |
Thesis (BS Biology) Cavite State University
Includes bibliographical references.
College of Arts and Science (CAS)
GATDULA, MAY MOJICA. Antimicrobial Susceptibility Profile of Enteric Bacterial Isolates from Tilapia (Oreochromis niloticus) and Bangus (Chanos chanos) Sold in Wet Markets. Cavite State University, Indang, Cavite. Adviser: Dr. Yolanda A. Ilagan.
This study was conducted to assess the antimicrobial susceptibility profile of enteric bacteria from tilapia and bangus. Ninety (90) bacteria were isolated by dilution plating using Cetrimide Agar (CA), Brilliant Green Agar (BGA), Violet Red Bile Agar (VRBA) and Eosin Methylene Blue (EMB). These isolates were identified based on their morphological and physiological characteristics. Disk diffusion assay was utilized to test the susceptibility of these bacterial isolates to the following antibiotics: ampicillin, clindamycin, oxacillin, norfloxacin, lincomycin, nitrorurantion, fosfomycin, ciprofloxacin, nalidixic acid, erythromycin, rifampicin, tetracyline, oxytetracycline, streptomycin and chloramphenicol. All isolates were resistant to rifampicin; 91.11% to clindamycin; 56.67% to ampicillin; 41.11% to oxacilllin; and 22.22% to chloramphenicol.
One hundred percent (90) of the isolates were susceptible to fosfomycin; 96% to ciprofloxacin; 87.78% to streptomycin; 86.67% to oxytetracyline and 80% nalidixic acid. This implies that fosfomycin, ciprofloxacin, streptomycin, oxytetracyline and nalidixic acid could be used in treating diseases of tilapia and bangus,
Submitted to the University Library 02/16/2011 T-4283